Pathogenesis of portal hypertensive gastropathy: Translating basic research into clinical practice

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 6, Issue 3, 2009, Pages 150-158

  Perini, Rafael F ^a   Camara, Paula R S ^b   Ferraz, Jose G P ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; PROTON PUMP INHIBITOR; SCLEROSING AGENT; SOMATOSTATIN; TERLIPRESSIN; TRANEXAMIC ACID; VASOCONSTRICTOR AGENT; VASOPRESSIN;

ALCOHOL WITHDRAWAL; ANEMIA; ARGON PLASMA COAGULATION; BACTERIAL COLONIZATION; BLOOD TRANSFUSION; CLINICAL PRACTICE; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; ELECTROCOAGULATION; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES BLEEDING; HELICOBACTER PYLORI; HUMAN; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; MEDICAL RESEARCH; NONHUMAN; PATHOGENESIS; PEPTIC ULCER; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STOMACH DISEASE; STOMACH INJURY; STOMACH MUCOSA; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT;

ANIMALS; DIFFUSION OF INNOVATION; HUMANS; HYPERTENSION, PORTAL; LIVER CIRRHOSIS; PORTAL PRESSURE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STOMACH DISEASES;

EID: 62549136518     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1356     Document Type: Review

References (84)

1. Rabinovitz M et al. (1990) Prevalence of endoscopic findings in 510 consecutive individuals with cirrhosis evaluated prospectively. Dig Dis Sci 35: 705-710
2. de Franchis R and Primignani M (2001) Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 5: 645-663
3. Terdiman JP (1997) The importance of accurate diagnosis and vigorous care of the patient with liver disease and gastrointestinal hemorrhage. Semin Gastrointest Dis 8: 166-178
4. Thiel H (1978) ["Hepatogenic ulcer": Theories and facts (author's transl)]. Z Gastroenterol 16: 73-84
5. McCormack TT et al. (1985) Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? Gut 26: 1226-1232
6. D'Amico G et al. (1990) Natural history of congestive gastropathy in cirrhosis. The Liver Study Group of V. Cervello Hospital. Gastroenterology 99: 1558-1564
7. Burak KW et al. (2001) Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome. Gut 49: 866-872
8. Burak KW and Beck PL (2003) Diagnosis of portal hypertensive gastropathy. Curr Opin Gastroenterol 19: 477-482
9. Ferraz JG and Wallace JL (1997) Underlying mechanisms of portal hypertensive gastropathy. J Clin Gastroenterol 25 (Suppl 1): S73-S78
10. Thalheimer U et al. (2005) Infection, coagulation, and variceal bleeding in cirrhosis. Gut 54: 556-563
11. Mookerjee RP et al. (2007) Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome. Hepatology 46: 831-840
12. Merli M et al. (2004) The natural history of portal hypertensive gastropathy in patients with liver cirrhosis and mild portal hypertension. Am J Gastroenterol 99: 1959-1965
13. Primignani M et al. (2000) Natural history of portal hypertensive gastropathy in patients with liver cirrhosis. The New Italian Endoscopic Club for the study and treatment of esophageal varices (NIEC). Gastroenterology 119: 181-187
14. Iwao T et al. (1992) Portal hypertensive gastropathy in patients with cirrhosis. Gastroenterology 102: 2060-2065
15. Sarin SK et al. (2000) The natural history of portal hypertensive gastropathy: Influence of variceal eradication. Am J Gastroenterol 95: 2888-2893
16. Zaman A et al. (1999) Factors predicting the presence of esophageal or gastric varices in patients with advanced liver disease. Am J Gastroenterol 94: 3292-3296
17. Carpinelli L et al. (1997) Portal hypertensive gastropathy: reproducibility of a classification, prevalence of elementary lesions, sensitivity and specificity in the diagnosis of cirrhosis of the liver. A NIEC multicentre study. New Italian Endoscopic Club. Ital J Gastroenterol Hepatol 29: 533-540
18. Primignani M et al. (2001) Portal hypertensive gastropathy in patients with cirrhosis of the liver. Recenti Prog Med 92: 735-740
19. Gupta R et al. (1996) Frequency and factors influencing portal hypertensive gastropathy and duodenopathy in cirrhotic portal hypertension. J Gastroenterol Hepatol 11: 728-733
20. Zaman A et al. (1999) Prevalence of upper and lower gastrointestinal tract findings in liver transplant candidates undergoing screening endoscopic evaluation. Am J Gastroenterol 94: 895-899
21. de Franchis R (2000) Updating consensus in portal hypertension: Report of the Baveno III Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension. J Hepatol 33: 846-852
22. Kamath PS et al. (2000) Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology 118: 905-911
23. de Melo MR et al. (2007) Portal hypertension in mansonic schistosomiasis: Repercussions of surgical treatment on the histomorphometric profile of the gastric mucosa. Rev Soc Bras Med Trop 40: 71-75
24. Soin AS et al. (1998) Portal hypertensive gastropathy in noncirrhotic patients. The effect of lienorenal shunts. J Clin Gastroenterol 26: 64-67
25. Ohta M et al. (1994) Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy. Hepatology 20: 1432-1436
26. Parikh SS et al. (1994) Congestive gastropathy: Factors influencing development, endoscopic features, Helicobacter pylori infection, and microvessel changes. Am J Gastroenterol 89: 1036-1042
27. Sarin SK et al. (1992) Prevalence, classification and natural history of gastric varices: A long-term follow-up study in 568 portal hypertension patients. Hepatology 16: 1343-1349
28. Panes J et al. (1992) Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology 103: 1875-1882
29. Bellis L et al. (2007) Hepatic venous pressure gradient does not correlate with the presence and the severity of portal hypertensive gastropathy in patients with liver cirrhosis. J Gastrointestin Liver Dis 16: 273-277
30. Tanoue K et al. (1992) Effects of endoscopic injection sclerotherapy on portal hypertensive gastropathy: A prospective study. Gastrointest Endosc 38: 582-585
31. de la Pena J et al. (1999) Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: Prospective randomized trial. Gastrointest Endosc 49: 417-423
32. Sarwar S et al. (2006) Effect of band ligation on portal hypertensive gastropathy and development of fundal varices. J Ayub Med Coll Abbottabad 18: 32-35
33. Sarin SK et al. (1997) Prospective randomized trial of endoscopic sclerotherapy versus variceal band ligation for esophageal varices: influence on gastropathy, gastric varices and variceal recurrence. J Hepatol 26: 826-832
34. Hou MC et al. (1995) Changes in portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation: An endoscopic observation. Gastrointest Endosc 42: 139-144
35. Yuksel O et al. (2006) Effects of esophageal varice eradication on portal hypertensive gastropathy and fundal varices: A retrospective and comparative study. Dig Dis Sci 51: 27-30
36. Kitano S and Dolgor B (2000) Does portal hypertension contribute to the pathogenesis of gastric ulcer associated with liver cirrhosis? J Gastroenterol 35: 79-86
37. Auroux J et al. (2003) Gastroduodenal ulcer and erosions are related to portal hypertensive gastropathy and recent alcohol intake in cirrhotic patients. Dig Dis Sci 48: 1118-1123
38. Akatsu T et al. (2006) Consequences of living-donor liver transplantation for upper gastrointestinal lesions: High incidence of reflux esophagitis. Dig Dis Sci 51: 2018-2022
39. Bahnacy A et al. (1996) Helicobacter pylori infection in congestive gastropathy. Helicobacter 1: 168-171
40. Chen LS et al. (1995) Prevalence of duodenal ulcer in cirrhotic patients and its relation to Helicobacter pylori and portal hypertension. Zhonghua Yi Xue Za Zhi (Taipei) 56: 226-231
41. Kamalaporn P et al. (2005) Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients. Aliment Pharmacol Ther 21: 1459-1465
42. Urso G et al. (2006) Role of Helicobacter pylori in patients with portal hypertensive gastropathy by liver cirrhosis hepatitis C virus-related. Minerva Gastroenterol Dietol 52: 303-308
43. Zullo A et al. (2003) Helicobacter pylori infection in patients with liver cirrhosis: Facts and fictions. Dig Liver Dis 35: 197-205
44. Sarfeh IJ et al. (1989) Impaired oxygenation of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury. Dig Dis Sci 34: 225-228
45. Piasecki C et al. (1995) Endoscopic detection of ischaemia with a new probe indicates low oxygenation of gastric epithelium in portal hypertensive gastropathy. Gut 36: 654-656
46. Wang F et al. (1995) The level of serum gastrin and ulceration in cirrhotic patients with portal hypertension [Chinese]. Zhonghua Wai Ke Za Zhi 33: 351-352
47. Lamarque D et al. (1994) Measurement of gastric intramucosal pH in patients with cirrhosis and portal hypertensive gastropathy. Gastroenterol Clin Biol 18: 969-974
48. Agnihotri N et al. (1997) Diminution in parietal cell number in experimental portal hypertensive gastropathy. Dig Dis Sci 42 431-439
49. Agnihotri N et al. (1998) Extrahepatic portal hypertensive gastropathy in Wistar rats: Modulation of acid secretion in isolated parietal cells. Dig Dis Sci 43: 56-66
50. Fraser AG et al. (1993) Gastric secretion and peptic ulceration in cirrhosis. J Hepatol 19: 171-182
51. Kang JY (1994) Peptic ulcer in hepatic cirrhosis and renal failure. J Gastroenterol Hepatol 9 (Suppl 1): S20-S23
52. Sarfeh IJ et al. (1983) Portal hypertension and gastric mucosal injury in rats. Effects of alcohol. Gastroenterology 84: 987-993
53. Kai S et al. (2007) Reduction of ethanol-induced injury in portal hypertensive gastric mucosa of rats by induction of heat shock protein 72 by geranylgeranylacetone. Wound Repair Regen 15: 875-880
54. Chaves DM et al. (2002) Comparative study of portal hypertensive gastropathy in schistosomiasis and hepatic cirrhosis. Endoscopy 34: 199-202
55. Beck PL et al. (1992) Characterization of spontaneous and ethanol-induced gastric damage in cirrhotic rats. Gastroenterology 103: 1048-1055
56. Beck PL et al. (1993) Prostaglandin modulation of the gastric vasculature and mucosal integrity in cirrhotic rats. Am J Physiol 265: G453-G458
57. Beck PL et al. (1993) Hepatic and gastric cytoprotective effects of long-term prostaglandin E1 administration in cirrhotic rats. Gastroenterology 105: 1483-1489
58. Geraldo J et al. (1996) Prostaglandins modulate the responsiveness of the gastric microcirculation of sodium nitroprusside in cirrhotic rats. Hepatology 23: 123-129
59. Wallace JL (1990) Mucosal defense. New avenues for treatment of ulcer disease? Gastroenterol Clin North Am 19: 87-100
60. Ferraz JG et al. (1995) Impaired vasodilatory responses in the gastric microcirculation of anesthetized rats with secondary biliary cirrhosis. Gastroenterology 108: 1183-1191
61. Ferraz JG et al. (1997) TNF-α contributes to the pathogenesis of ethanol-induced gastric damage in cirrhotic rats. Am J Physiol 272: G809-G814
62. Lee SS and Sharkey KA (1993) Capsaicin treatment blocks development of hyperkinetic circulation in portal hypertensive and cirrhotic rats. Am J Physiol 264: G868-G873
63. Li Y et al. (2003) Effect of neonatal capsaicin treatment on haemodynamics and renal function in cirrhotic rats. Gut 52: 293-299
64. Song D et al. (2001) Disordered central cardiovascular regulation in portal hypertensive and cirrhotic rats. Am J Physiol Gastrointest Liver Physiol 280: G420-G430
65. Camara PRS et al. (2008) Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats. Eur J Pharmacol 589: 245-250
66. Holzer P (1998) Neural emergency system in the stomach. Gastroenterology 114: 823-839
67. Ohta M et al. (1997) Overexpression of endothelin-1 mRNA and protein in portal hypertensive gastric mucosa of rats: A key to increased susceptibility to damage? Surgery 122: 936-942
68. Moezi L et al. (2006) Anandamide mediates hyperdynamic circulation in cirrhotic rats via CB(1) and VR(1) receptors. Br J Pharmacol 149: 898-908
69. Bruha R et al. (2002) Double-blind randomized, comparative multicenter study of the effect of terlipressin in the treatment of acute esophageal variceal and/or hypertensive gastropathy bleeding. Hepatogastroenterology 49: 1161-1166
70. Zhou Y et al. (2002) Comparison of the efficacy of octreotide, vasopressin, and omeprazole in the control of acute bleeding in patients with portal hypertensive gastropathy: A controlled study. J Gastroenterol Hepatol 17: 973-979
71. Kouroumalis EA et al. (1998) Somatostatin for acute severe bleeding from portal hypertensive gastropathy. Eur J Gastroenterol Hepatol 10: 509-512
72. Panes J et al. (1994) Reduction of gastric hyperemia by glypressin and vasopressin administration in cirrhotic patients with portal hypertensive gastropathy. Hepatology 19: 55-60
73. Perez-Ayuzo RM et al. (1991) Propranolol in prevention of recurrent bleeding from severe portal hypertensive gastropathy in cirrhosis. Lancet 337: 1431-1434
74. McCormick PA et al. (1998) Tranexamic acid for severe bleeding gastric antral vascular ectasia in cirrhosis. Gut 42: 750-752
75. Tzathas C et al. (2008) Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: A prospective, cohort 2-year follow-up study. J Clin Gastroenterol 42: 744-749
76. Wagatsuma Y et al. (2006) Clinical usefulness of the angiotensin II receptor antagonist losartan in patients with portal hypertensive gastropathy. Hepatogastroenterology 53: 171-174
77. Wong F (2006) The use of TIPS in chronic liver disease. Ann Hepatol 5: 5-15
78. Bosch J and Abraldes JG (2004) Management of gastrointestinal bleeding in patients with cirrhosis of the liver. Semin Hematol 41: 8-12
79. Mezawa S et al. (2001) Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation. Am J Gastroenterol 96: 1155-1159
80. Hiraga N et al. (2007) The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol 42: 663-672
81. Yoshida H et al. (2008) Partial splenic embolization. Hepatol Res 38: 225-233
82. Akatsu T et al. (2006) Consequences of living-donor liver transplantation for upper gastrointestinal lesions: High incidence of reflux esophagitis. Dig Dis Sci 51: 2018-2022
83. Sato T et al. (2005) Efficacy of argon plasma coagulation for gastric antral vascular ectasia associated with chronic liver disease. Hepatol Res 32: 121-126
84. Clarke JO and Thuluvath PJ (2007) Endoscopic frontiers in the field of hepatology. Minerva Gastroenterol Dietol 53: 101-109